These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1184196)

  • 21. [Evidence of hepatitis-B antigen in laboratory diagnosis of conditions affecting the liver and in healthy subjects (author's transl)].
    Mayerová A; Zacharová M; Cervenka J
    Bratisl Lek Listy; 1976 Jul; 66(1):66-71. PubMed ID: 974844
    [No Abstract]   [Full Text] [Related]  

  • 22. [Carriers of hepatitis B antigen. Studies by immunofluorescence for hepatic localization of the antigen].
    Turbessi G; De Bac C; Caramia F; Ricci G
    Recenti Prog Med; 1974; 56(3):212-29. PubMed ID: 4596326
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis beta-antigen titer and subtypes of acute and chronic hepatitis].
    Babes VT; Lenkei R; Dumitrescu D
    Acta Biol Med Ger; 1975; 34(7):1289-91. PubMed ID: 812315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogenetic aspects of immunoglobulins of HAA positive and HAA negative liver diseases (author's transl)].
    Reis HE; Bertrams J; Kuwert E; Selmair H; Wiese W
    Med Klin; 1974 Sep; 69(39):1579-86. PubMed ID: 4456161
    [No Abstract]   [Full Text] [Related]  

  • 25. [Data on hepatitis antigen (HAA)].
    Renger F; Reimann W; Frank J; Kobe E; Vogel C; Vogel H; Kayser W; Bosse W; Geyer F
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):83-6. PubMed ID: 4347640
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinico-pathological studies of the liver in asymptomatic carriers of Australia antigen.
    Ichida F; Sasaki H; Sekine T; Inagaki T
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):13-21. PubMed ID: 1119298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic liver disease and hepatitis-B antigen: a prospective study.
    Van Waes L; Segers J; Van Egmond J; Van Nimmen L; Barbier F; Wieme R; Demeulenaere L
    Br Med J; 1974 Aug; 3(5928):444-6. PubMed ID: 4212993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases.
    Piccinino F; Manzillo G; Sagnelli E; Balestrieri GG; Maio G; Pasquale G; Felaco FM
    Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):171-8. PubMed ID: 665117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term outcome of hepatitis B.
    Norkrans G; Hermodsson S; Lundin P; Iwarson S
    Infection; 1976; 4(2):70-2. PubMed ID: 947848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus.
    Heathcote J; Gateau P; Sherlock S
    Lancet; 1974 Aug; 2(7877):370-1. PubMed ID: 4137173
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative evaluation of some methods for detection of Australia antigen (HBAg) in the serum of acute hepatitis].
    Giuliani G; Castelletti GC; Novara O; Paggi GC; Varetti G
    Quad Sclavo Diagn; 1975 Jun; 11(2):516-22. PubMed ID: 817361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radioimmunoquantization of the HBAg in clinical liver diseases].
    De Ritis F; Gravina E; Squame G; Celentano L
    Quad Sclavo Diagn; 1975 Jun; 11(2):446-62. PubMed ID: 1223948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of hepatitis B antigen and antibody in hospital patients in Copenhagen.
    Skinhoj P
    Scand J Infect Dis; 1975; 7(2):85-9. PubMed ID: 1179171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.
    Arnold W; Hess G; Kawakami H; Meyer zum Büschenfelde KH
    Klin Wochenschr; 1981 Jun; 59(12):679-83. PubMed ID: 7253542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australia antigen in Jerusalem.
    Fainaru M; Gorsky Y
    Isr J Med Sci; 1972 Jan; 8(1):7-10. PubMed ID: 5026866
    [No Abstract]   [Full Text] [Related]  

  • 36. [Demonstration of hepatitis B antigen in relation to the behavior of liver indicator-enzymes patients with viral hepatitis].
    Borón P; Sokolewicz-Bobrowska E; Dzikowski M
    Z Gesamte Inn Med; 1974 Dec; 29(24):1016-18. PubMed ID: 4458317
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Australia antigen in liver damage and the possibility of selecting virus hepatitis (author's transl)].
    Hrachovina V; Kratochvílová V; Libich M
    Cesk Epidemiol Mikrobiol Imunol; 1974 Jan; 23(1):41-5. PubMed ID: 4280939
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incidence of Australia antigen (HBs Ag) in a group of apparently healthy population of the Sassari province].
    Scalise G; Maida A; Pettinato S; Mura MS; Spanedda M
    Ann Sclavo; 1975; 17(3):299-310. PubMed ID: 1230041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic liver disease in hepatitis B antigen carriers.
    Woolf IL; Boyes BE; Jones DM; Whittaker JS; Tapp E; MacSween RN; Renton PH; Stratton F; Dymock IW
    J Clin Pathol; 1974 May; 27(5):348-52. PubMed ID: 4850682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.